• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

DC8:GR

0.631 EUR 0.019 2.92%

As of 15:18:20 ET on 12/23/2014.

Snapshot for Durect Corp (DC8)

Open: 0.619 Day's Range: 0.615 - 0.654 Volume: 60
Previous Close: 0.650 52wk Range: 0.531 - 1.647 1-Yr Rtn: -46.84%

Stock Chart for DC8

No chart data available.
  • DC8:GR 0.654
  • 1D
  • 1M
  • 1Y
0.650
Interactive DC8 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DC8

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1950
Est. PEG Ratio -
Market Cap (M EUR) 71.73
Shares Outstanding (M) 113.68
30 Day Average Volume 269
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DC8

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DC8

Durect Corporation develops and commercializes pharmaceutical systems for the treatment of chronic diseases. The pharmaceutical systems provide therapy for chronic diseases or conditions by replacing multiple injection therapy or oral dosing, improving drug efficacy, reducing side effects, and ensuring dosing compliance.

Felix TheeuwesChairman/Chief Scientific OfcrJames E BrownPresident/CEO/Co-Founder
Matthew J HoganChief Financial OfficerSu Il YumExec VP:Pharmaceutical Sys
More Company Profile & Key Executives for DC8

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil